Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Belief BioMed Reports Positive Data for Hemophilia Gene Therapy

CARsgen Reports Positive Results for CAR T Therapy in Solid Tumor Cancers

Binhui Raises $47 Million for Oncolytic Virus Products

ImmVira to Test its 3-in-1 Virus Delivery Product with Roche’s MEK Inhibitor

Pregene Out-licenses CAR-T to CellPoint for $22 Million in Near-Term Payments

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022